|
hsa04062
|
Chemokine signaling pathway
|
15
|
8.37E-06
|
STAT2,CCL3L3,NRAS,RAP1A,CXCL1,RAP1B,CCL3,GNAI3,IL8,ADCY4,PIK3R1,PTK2,CCL4,JAK2,PRKACB
|
|
hsa05144
|
Malaria
|
8
|
2.26E-05
|
IL1B,IL6,HBD,SDC4,GYPC,THBS1,IL8,ICAM1
|
|
hsa04670
|
Leukocyte transendothelial migration
|
10
|
2.07E-04
|
MLLT4,RAP1A,RAP1B,GNAI3,ARHGAP5,ICAM1,PIK3R1,PTK2,ITGB1,MYL12A
|
|
hsa04621
|
NOD-like receptor signaling pathway
|
7
|
4.20E-04
|
IL1B,NLRP1,IL6,TNFAIP3,CXCL1,BIRC3,IL8
|
|
hsa05142
|
Chagas disease (American trypanosomiasis)
|
9
|
4.85E-04
|
IL1B,IL6,CCL3L3,PPP2R2A,CCL3,GNAI3,IL8,IFNGR1,PIK3R1
|
|
hsa05323
|
Rheumatoid arthritis
|
8
|
4.86E-04
|
IL1B,IL6,ATP6V1C1,CCL3L3,CXCL1,CCL3,IL8,ICAM1
|
|
hsa04010
|
MAPK signaling pathway
|
14
|
4.97E-04
|
IL1B,NRAS,RAP1A,RASA2,PPM1A,LAMTOR3,RAP1B,PLA2G6,DUSP5,NR4A1,CACNB3,DUSP2,PRKACB,MAP3K8
|
|
hsa03010
|
Ribosome
|
8
|
5.05E-04
|
RPS3A,UBA52,RSL24D1,RPL7,RPL39,RPL21,RPS24,RPS12
|
|
hsa05146
|
Amoebiasis
|
8
|
1.26E-03
|
IL1B,IL6,CXCL1,SERPINB2,IL8,PIK3R1,PTK2,PRKACB
|
|
hsa04510
|
Focal adhesion
|
11
|
1.31E-03
|
PTEN,RAP1A,THBS1,BIRC3,RAP1B,ITGA5,ARHGAP5,PIK3R1,PTK2,ITGB1,MYL12A
|
|
hsa05162
|
Measles
|
9
|
1.33E-03
|
IL1B,IL6,STAT2,TBK1,TNFAIP3,IFNGR1,PIK3R1,JAK2,OAS1
|
|
hsa04620
|
Toll-like receptor signaling pathway
|
8
|
1.43E-03
|
IL1B,IL6,TBK1,CCL3,IL8,PIK3R1,CCL4,MAP3K8
|
|
hsa05222
|
Small cell lung cancer
|
7
|
2.02E-03
|
BCL2L1,PTEN,BIRC3,PIK3R1,PTK2,ITGB1,PTGS2
|
|
hsa04210
|
Apoptosis
|
7
|
2.17E-03
|
IL1B,BCL2L1,BIRC3,PIK3R1,IRAK3,PRKACB,ATM
|
|
hsa05145
|
Toxoplasmosis
|
8
|
3.37E-03
|
BCL2L1,BIRC3,PLA2G6,GNAI3,IFNGR1,PIK3R1,ITGB1,JAK2
|
